3079 Stock Overview
DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
DVx Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥997.00 |
| 52 Week High | JP¥1,114.00 |
| 52 Week Low | JP¥810.00 |
| Beta | 0.23 |
| 1 Month Change | 0.30% |
| 3 Month Change | -7.34% |
| 1 Year Change | -1.97% |
| 3 Year Change | 2.36% |
| 5 Year Change | 12.02% |
| Change since IPO | 406.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3079 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.1% | 1.1% | 1.4% |
| 1Y | -2.0% | 4.2% | 28.4% |
Return vs Industry: 3079 underperformed the JP Healthcare industry which returned 4.2% over the past year.
Return vs Market: 3079 underperformed the JP Market which returned 28.4% over the past year.
Price Volatility
| 3079 volatility | |
|---|---|
| 3079 Average Weekly Movement | 2.2% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 3079 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3079's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 319 | Hiroshi Shibasaki | www.dvx.jp |
DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. The company offers arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters; ischemia-related products, that includes RAQUOS and resolution/resolution SD; and EPS Trainer, an intracardiac electrograms simulator; and wonder belt products. The company also engages in the design, manufacture, and purchasing/selling of medical computers; manufacture, purchasing/selling, repair, maintenance and inspection, rental, leasing, and import/export of medicines, quasi drugs, cosmetics, health foods, daily goods, nursing care products, and nursing care equipment; provision of internal and external medical and medical device-related general consulting and services, as well as medical publishing and market research services; and sale and purchase of second hand goods.
DVx Inc. Fundamentals Summary
| 3079 fundamental statistics | |
|---|---|
| Market cap | JP¥9.77b |
| Earnings (TTM) | JP¥398.00m |
| Revenue (TTM) | JP¥46.19b |
24.6x
P/E Ratio0.2x
P/S RatioIs 3079 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3079 income statement (TTM) | |
|---|---|
| Revenue | JP¥46.19b |
| Cost of Revenue | JP¥41.25b |
| Gross Profit | JP¥4.95b |
| Other Expenses | JP¥4.55b |
| Earnings | JP¥398.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 40.60 |
| Gross Margin | 10.71% |
| Net Profit Margin | 0.86% |
| Debt/Equity Ratio | 0% |
How did 3079 perform over the long term?
See historical performance and comparison